Elosan Efficacy Study (EES)
CompletedNot applicableNCT03823729
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The "Elosan Cabin" is a closed, electrically insulated, biocompatible cabin for the short-term application of electrostatic high voltage in patients with chronic pain, especially those with rheumatic diseases. Patients assigned to the Elosan group (group A) will have 8 sessions in the Elosan cabin, with an interval of 3 to 4 days between sessions. Patients assigned to the control group (group B) will have no treatment except for the continuation of their prescribed pain medication and pain therapy.
Study details
- Official title
- A Randomized, Open, Comparative Clinical Investigation to Show the Efficacy of a Short Time, Whole Body, Electrostatic High Voltage Application for Relief of Chronic Pain. Included in Study Can be Persons Suffering From Chronic Pain as it is Often Case With Rheumatic Disease or Traumata
- Conditions
- Interventions
- Device: Elosan Cabin
- Sponsor
- Elosan AG
- Start date
- 2018-07-18
- Primary completion
- 2019-03-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Switzerland
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Informed Consent * adults, age ≥ 18 years, male or female patients * History of pain ≥ 6 months * Suffering from chronic pain, either reumatic pain or pain caused by traumata * Intensity of pain rated ≥ 50 mm on VAS pain Exclusion Criteria: * Untreated thyroid disease * History of seizure disorder (epilepsy) * History of or current psychosis * Women who are pregnant, breast feeding or intending to become pregnant * Patients who are currently participating in other studies or have participated in other studies within the last 30 days * Patients who have expressed their intention, or are suspected of intending, to discontinue therapy or stop therapy before the end of trial * Patients with an electric or electronic implant.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03823729